|
Thursday 25th May 2017 |
Text too small? |
SeaDragon, which manufactures fish oils for health supplements, confirmed its 2017 annual loss would widen, in line with its previous guidance.
The Nelson-based fish oil refiner said its management and auditors are currently working through the year-end audit process, and it expects to report a loss of $4.3 million to $4.5 million on a normalised earnings before interest, tax, depreciation and amortisation basis, versus a 2016 loss of $400,000. That's in line with its previous guidance released March 1.
The earnings for the year ended March 31 will be released on of before May 31, the company said.
SeaDragon has previously attributed the loss to the length of time it has taken to transition from its legacy Omega-2 business to Omega-3 fish oil produced by its new refinery.
The shares were unchanged at 0.6 cents and have fallen 50 percent over the past year.
(BusinessDesk)
No comments yet
September 2nd Morning Report
TWL - Amendments to Notice of Annual Shareholders' Meeting
Devon Funds Morning Note - 01 September 2026
September 1st Morning Report
Devon Funds Morning Note - 31 August 2026
PCT - Precinct FY26 Annual Results
PYS - Mark Samlal retires as PaySauce Director
HGH - Heartland confirms receipt of Toi Foundation approval
SCT - Scott Targets NZ$165m in Protein Revenue by FY30
KPG - Kiwi Property FY27 first quarter dividend payment